The Efficacy and Safety of Eravacycline in the Treatment of Complicated Intra-Abdominal Infections: A Systemic Review and Meta-Analysis of Randomized Controlled Trials.

J Clin Med · 2019 · PMC6617347 · PMID 31212991

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Although the risks of nausea and vomiting in the eravacycline group were higher than those in the comparator group, these differences did not reach statistical significance (for nausea, RR, 4.79; 95% CI, 0.84–27.14;7 I 2 = 70%, for vomiting, RR, 1.46; 95% CI, 0.76–2.81;7 I 2 = 0%). 4.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.